Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-27.03%
End price
14.12.24
€2.70
Summary
This prediction ended on 14.12.24 with a price of €2.70. The prediction for Leap Therapeutics Inc. disappointed with a performance of -27.03%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Leap Therapeutics Inc. | -12.756% | -12.756% | 145.513% |
| iShares Core DAX® | 3.593% | 3.931% | 15.378% |
| iShares Nasdaq 100 | 5.810% | 5.518% | 41.455% |
| iShares Nikkei 225® | 4.075% | 8.460% | 48.947% |
| iShares S&P 500 | 4.142% | 4.039% | 31.594% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year